• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症谱系障碍患者长效注射抗精神病药物治疗中断和住院的预测因素。

Predictors of discontinuation and hospitalization during long-acting injectable antipsychotic treatment in patients with schizophrenia spectrum disorder.

机构信息

Department of Psychiatry, Istanbul Faculty of Medicine, Istanbul University, Istanbul.

Department of Psychiatry, Faculty of Medicine, Hacettepe University, Ankara.

出版信息

Int Clin Psychopharmacol. 2021 Mar 1;36(2):89-96. doi: 10.1097/YIC.0000000000000348.

DOI:10.1097/YIC.0000000000000348
PMID:33512962
Abstract

The aim of this study was to evaluate discontinuation and hospitalization rates in patients with schizophrenia spectrum disorder who were treated with long-acting injectable (LAI) antipsychotics. We recorded clinical data about the period before the LAI treatment, when LAI treatment was initiated, and during the LAI treatment. Variables related to early (<8 weeks) and other LAI discontinuations and hospitalization were analyzed. Out of 452 patients, 14.4% of them discontinued their LAI treatment before 8 weeks, another 24.8% of the patients stopped their LAI by themselves later. Early discontinuers were younger, had shorter duration of illness, and less educated. Sixty-two (27.2%) of the patients were hospitalized under LAI treatment and 40% of the hospitalizations occurred in initial 6 months. Rate of hospitalization was 36.1% in the group who discontinued LAI after 8 weeks. In logistic regression analysis, younger age, history of combined antipsychotic treatment, number of hospitalizations before LAI, use of LAI for less than 6 months and alcohol abuse under LAI treatment were found related to hospitalization. Our findings suggested that discontinuation and hospitalization are still common among the patients who were treated with LAI antipsychotics.

摘要

本研究旨在评估接受长效注射(LAI)抗精神病药物治疗的精神分裂症谱系障碍患者的停药和住院率。我们记录了 LAI 治疗前、开始 LAI 治疗时和 LAI 治疗期间的临床数据。分析了与早期(<8 周)和其他 LAI 停药和住院相关的变量。在 452 名患者中,有 14.4%的患者在 8 周前停止了 LAI 治疗,另有 24.8%的患者后来自行停止了 LAI 治疗。早期停药者更年轻,发病时间更短,受教育程度更低。62 名(27.2%)患者在 LAI 治疗期间住院,40%的住院发生在最初的 6 个月内。在 8 周后停止 LAI 的患者中,住院率为 36.1%。在逻辑回归分析中,年龄较小、合并抗精神病药物治疗史、LAI 治疗前的住院次数、LAI 治疗少于 6 个月以及 LAI 治疗期间酗酒与住院有关。我们的研究结果表明,在接受 LAI 抗精神病药物治疗的患者中,停药和住院仍然很常见。

相似文献

1
Predictors of discontinuation and hospitalization during long-acting injectable antipsychotic treatment in patients with schizophrenia spectrum disorder.精神分裂症谱系障碍患者长效注射抗精神病药物治疗中断和住院的预测因素。
Int Clin Psychopharmacol. 2021 Mar 1;36(2):89-96. doi: 10.1097/YIC.0000000000000348.
2
Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.精神分裂症或双相情感障碍患者中长效注射用与口服抗精神病药物的用药依从性及停药情况
J Med Econ. 2018 Feb;21(2):127-134. doi: 10.1080/13696998.2017.1379412. Epub 2017 Sep 29.
3
Comparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study.利培酮长效注射剂与第一代抗精神病长效注射剂治疗精神分裂症的比较疗效:一项全国性回顾性起始队列研究的结果
Schizophr Bull. 2015 May;41(3):627-36. doi: 10.1093/schbul/sbu128. Epub 2014 Sep 1.
4
Patterns of long acting injectable antipsychotic use and associated clinical factors in schizophrenia among 15 Asian countries and region.15 个亚洲国家和地区精神分裂症患者中长效注射抗精神病药物的使用模式及相关临床因素。
Asia Pac Psychiatry. 2020 Dec;12(4):e12393. doi: 10.1111/appy.12393. Epub 2020 May 29.
5
Clinical evolution of patients treated with aripiprazole long-acting injectable: a preliminary, prospective, observational study.阿立哌唑长效注射剂治疗患者的临床演变:一项初步的、前瞻性、观察性研究。
Int J Psychiatry Clin Pract. 2020 Mar;24(1):10-17. doi: 10.1080/13651501.2019.1711130. Epub 2020 Jan 14.
6
Hospitalization resource utilization and costs among Medicaid insured patients with schizophrenia with different treatment durations of long-acting injectable antipsychotic therapy.医疗保险参保的精神分裂症患者中,不同长效注射抗精神病药物治疗持续时间患者的住院资源利用和费用。
J Clin Psychopharmacol. 2014 Feb;34(1):30-5. doi: 10.1097/JCP.0b013e3182a6082a.
7
Differences in Antipsychotic Treatment Discontinuation Among Veterans With Schizophrenia in the U.S. Department of Veterans Affairs.美国退伍军人事务部中精神分裂症退伍军人的抗精神病药物治疗停药差异。
Am J Psychiatry. 2021 Oct 1;178(10):932-940. doi: 10.1176/appi.ajp.2020.20111657. Epub 2021 Jul 14.
8
Effectiveness and Predictors of Discontinuation of Aripiprazole Long-acting Injection: A 12-Month Naturalistic Cohort Study.阿立哌唑长效注射剂停药的效果和预测因素:一项为期 12 个月的自然队列研究。
J Clin Psychopharmacol. 2021;41(4):478-483. doi: 10.1097/JCP.0000000000001437.
9
Continuation of schizophrenia treatment with three long-acting injectable antipsychotics in South Korea: A nationwide population-based study.韩国三种长效注射抗精神病药物治疗精神分裂症的延续:一项全国性基于人群的研究。
Eur Neuropsychopharmacol. 2019 Sep;29(9):1051-1060. doi: 10.1016/j.euroneuro.2019.07.138. Epub 2019 Jul 27.
10
Predictors of long-acting injectable antipsychotic treatment discontinuation in outpatients with schizophrenia: relevance of the Drug Attitude Inventory-10.预测精神分裂症门诊患者长效注射抗精神病药物治疗中断的因素:药物态度量表-10 的相关性。
Int Clin Psychopharmacol. 2021 Jul 1;36(4):181-187. doi: 10.1097/YIC.0000000000000359.

引用本文的文献

1
Implementing gradual, hyperbolic tapering of long-acting injectable antipsychotics by prolonging the inter-dose interval: an modelling study.通过延长给药间隔实施长效注射用抗精神病药物的渐进性、双曲线式减量:一项建模研究。
Ther Adv Psychopharmacol. 2023 Sep 13;13:20451253231198463. doi: 10.1177/20451253231198463. eCollection 2023.
2
High Rate of Discontinuation during Long-Acting Injectable Antipsychotic Treatment in Patients with Psychotic Disorders.精神障碍患者长效注射用抗精神病药物治疗期间的高停药率
Biomedicines. 2023 Jan 22;11(2):314. doi: 10.3390/biomedicines11020314.
3
Clinical Utility of Fluid Biomarker in Depressive Disorder.
液体生物标志物在抑郁症中的临床应用
Clin Psychopharmacol Neurosci. 2022 Nov 30;20(4):585-591. doi: 10.9758/cpn.2022.20.4.585.